Logo Eclevar
Book a Consultation

eCOA

eCRF

Survey

DCT

The #1 All-in-One Solution for Your Next Clinical Trials

eCRF (Electronic Case Report Forms)

Build, Recruit, and Monitor Your Study from a Single Platform. Connect Clinicians, Hospitals, Industry Professionals, CROs, and Patients

eCRF

Milo eCRF - The Next-Generation EDC Platform for Medical Devices

Milo eCRF is a fully customizable and intuitive Electronic Data Capture (EDC) solution, validated according to ISO 14155:2020 standards. It is designed for medical device manufacturers who want to conduct compliant, efficient, and remotely monitored clinical trials.

eCRF

1. Turn your data into proactive decisions

  • Access to fully customizable dashboards
  • View important data (patients, sites, forms)
  • AI-driven insights with user-defined rules
  • Anticipate risks before they arise

2. Create eCRFs and surveys in seconds

  • Intuitive drag-and-drop builder
  • No coding required
  • Creation of PROs, safety reports, clinical criteria
  • Simple and compliant deployment
eCRF
eCRF

3. Monitor recruitment and study progress in real time

  • Tracking patient visits, screening failures, inclusion milestones
  • Dynamic dashboards updated automatically
  • Instant alerts for queries or delays
  • Complete control over site performance and schedules

Boost your clinical trials with our Milo Healthcare platform

Transform your medical device research with our comprehensive EDC solution. From AI-powered patient recruitment to real-time data analytics, Milo Healthcare streamlines every aspect of your clinical trials while ensuring full regulatory compliance.

Easy to manage your data
Collaborate securely
Accelerate your clinical research
Real time analysis
eCRF
15-Minute Free Consultation

Milo eCRF

0 %
Finalization of the eCRF
0 % + faster
Cleaned data
0 %
Simplified export of CERs
eCRF

More than 43 leading global MedTech companies trust the Milo platform

eCRF
eCRF
eCRF
eCRF
eCRF
eCRF
eCRF
eCRF

Our partners and the medical devices association

eCRF
eCRF
ECLEVAR MEDTECH is a global medical device CRO, headquartered in Paris. We support medical device manufacturer in the MDR and IVDR transition.
ECLEVAR MEDTECH is a global medical device CRO, headquartered in Paris. We support medical device manufacturer in the MDR and IVDR transition.
ECLEVAR MEDTECH is a global medical device CRO, headquartered in Paris. We support medical device manufacturer in the MDR and IVDR transition.
ECLEVAR MEDTECH is a global medical device CRO, headquartered in Paris. We support medical device manufacturer in the MDR and IVDR transition.
ECLEVAR MEDTECH is a global medical device CRO, headquartered in Paris. We support medical device manufacturer in the MDR and IVDR transition.
ECLEVAR MEDTECH is a global medical device CRO, headquartered in Paris. We support medical device manufacturer in the MDR and IVDR transition.
ECLEVAR MEDTECH is a global medical device CRO, headquartered in Paris. We support medical device manufacturer in the MDR and IVDR transition.

Benefits of using an electronic data capture system in clinical trials

Collect scientifically valid PMCF data that complies with the MDR using our platform:

  • GDPR compliance made easy.
  • Easily comply with GDPR requirements for informed consent and data protection.
  • Our in-house data protection officer monitors compliance for all studies.
  • Benefits of using an electronic data capture system in clinical trials: Our partners and the medical device association…

Pre-validated and compliant data platform: Our platform meets the requirements of ISO14155:2020 and GDPR.

  • Fully documented data traceability.
  • All data entries automatically include user identification to ensure fully documented traceability from source to sponsor using advanced AI technology.
Logo Eclevar

+

eCRF

=

Unmatched expertise to conduct your trials with assured quality and provide patients with safe and innovative therapies.

“Conducting clinical trials can be overwhelming due to documentation and compliance tasks—but with Milo, everything has become easier, faster, and more manageable.” Unmatched expertise to conduct your trials with assured quality and provide patients with safe and innovative therapies.“
Dr. Axel Schulz, Orthopedic and Trauma Surgeon​
Dr. Axel Schulz, Orthopedic and Trauma Surgeon​OSSUR
“Highly innovative and powerful for our trial on diabetic foot ulcers.”
Antoine Turzi, CEO​
Antoine Turzi, CEO​RegenLab​
"We tested Milo in a clinical trial, and it was extraordinary and promising for advancing research."
Prof. Luc Teot, Director of Cicat-Occitanie
Prof. Luc Teot, Director of Cicat-OccitanieCHU Montpellier​
Previous
Next

TESTIMONIAL - Interview with Dr. Axel Schulz on simplifying clinical trials with Milo

Axel Schulz, an orthopedic surgeon and traumatologist based in Germany, on his experience using the Milo digital platform to support patient documentation and engagement during clinical trials.

Register with the French health data center.

As shown in the clinical evaluation report, the claims regarding safety and clinical performance are not sufficiently supported by existing clinical evidence.

To keep the “vascular device” on the European market, the client must conduct a PMCF study to generate sufficient clinical data in accordance with “Chapter VI – Clinical evaluation and clinical investigations, in particular sections 62 to 82” and ISO 14155:2020.

Objectives

  • Confirm the safety and performance of the vascular device throughout its expected lifetime at two anatomical sites: carotid and femoral.
  • Identify and analyze emerging risks based on factual data.Ensure continued acceptance of the benefit-risk ratio in accordance with the EU-MDR.
  • Identify any systematic or non-compliant misuse of product X in order to verify that the intended use is correct.

Methodology

  • A sponsor conducted a multicenter study on EFR to collect clinical data on the vascular device. The objective was to examine the short- and long-term results of using the device when exposed to a larger and more diverse population.
  • 300 subjects were evaluated at three different sites, including 150 in the carotid position and at least 150 in the femoral position.

Advantages

  • Contributes to the development of a broader body of evidence.
    Representative population.
  • Accepted by the notified body for the MDR certificate.
  • Limitations: Incomplete long-term evidence.


Solution: Creation of a European vascular registry

Access the Eclevar Knowledge Center

15-Minute Free Consulting

Got a question, an idea, or a project in mind? Get 15 minutes with one of our experts—no strings attached. Just a quick, constructive chat to help you move forward with confidence.

Book your free session now
eCRF

Legal notices

VISIT US

ECLEVAR HEALTHTECH:
75380 58 RUE DE MONCEAU 75008 PARIS

ECLEVAR GMBH
ERFURT, Erfurt Hauptbahnhof
4th, 5th floor
Bahnhofstr. 38 Erfurt 99084

ECLEVAR Australia
Umina Beach NSW 2257, Australia

ECLEVAR UK Limited
3rd Floor 207 Regent Street, London, W1B 3HH

CONTACT US

OUR SERVICES

Get your copy of our new whitepaper today!

eCRF
DOWNLOAD NOW